Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 17 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
161 28.0 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Salvatore Hospital Italy 10/2010
Treatment Details: Patients: This phase II study involved 50 metastatic colorectal cancer patients with a median age of 63 years; 31 were male. Treatment: Patients were treated with a combination of the c
 
162 28.0 months Advanced breast cancer 5 Chemotherapy
Helsinki University Central Hospital Finland 5/2010
Treatment Details: Patients: For this study, women with advanced breast cancer were divided into two separate treatment groups. Group A consisted of 115 patients with a median age of 55 years (range of 31-69
 
163 28.0 months Metastatic breast cancer 5 Chemotherapy
Immunotherapy
Princess Margaret Hospital Canada 1/2008
Treatment Details: Patients: This study initially involved 386 women with metastatic breast cancer. Of this group, 224 women responded to initial chemotherapy and agreed to be in the study comparing differen
 
164 27.9 months Recurrent ovarian cancer 4 Chemotherapy
Far Eastern Memorial Hospital Taiwan Region 1/2009
Treatment Details: Patients: This phase 2 study involved 32 women with recurrent platinum-sensitive ovarian cancer. The median age was 56, ranging from 42 to 82 years of age. Most had one previous chemothera
 
165 27.9 months Advanced NSCLC 5 Chemotherapy
Radiation
La Fe University Hospital Spain 4/2014
Treatment Details: Patients: This phase 2 study involved 48 advanced non-small cell lung cancer patients. The median patient age was 61 years and 89.6% were male. Treatment: Patients received radiation t
 
166 27.7 months Indolent NHL 4 Biologic therapy
US Oncology Research Inc United States 1/2010
Treatment Details: Patients: This phase 2 study involved 60 relapsed or refractory indolent lymphoma patients who were previously treated with rituximab. The median patient age was 70 years and 47% were male
 
167 27.7 months Metastatic breast cancer 4 Chemotherapy
Northwestern University United States 10/2012
Treatment Details: Patients: This phase 2 study involved metastatic breast cancer patients who were divided into two separate treatment groups. Group A consisted of 76 women with a median age of 51.7 years.
 
168 27.6 months NHL 4 Immunotherapy
Mayo Clinic and Mayo Foundation United States 7/2007
Treatment Details: Patients: This study involved 41 patients with non-Hodgkin’s lymphoma. The median patient age was 65 years and 44% were male. Treatment: Patients were treated with the immunotherapy ag
 
169 27.6 months Metastatic colorectal cancer 4 Chemotherapy
Nihon University School of Medicine Japan 3/2011
Treatment Details: Patients: This phase II study involved 58 patients with metastatic colorectal cancer, 36 of whom were male. The median patient age was 67.5 years. Treatment: Patients were treated with
 
170 27.6 months Advanced, non-metastatic rectal 4 Chemotherapy
Radiation
Surgery
Universitat Heidelberg Germany 3/2007
Treatment Details: Patients: This phase II study involved 36 patients with advanced, non-metastatic rectal cancer. Of these, 33 had newly diagnosed rectal adenocarcinoma and 3 a local recurrence at the anast
 
Page 17 of 187  | Previous Page  | Next Page